Results 261 to 270 of about 80,027 (384)

Long-term BPV is an Independent Risk Factor for Renal Prognosis in Hypertensive Patients - a Post-hoc Analysis of the SPRINT Study. [PDF]

Int J Med Sci
Ruan Y, Chen Y, Huang N, Wang D, Xu Y, Fan J, Chen W, Wang X.   +7 more
europepmc   +1 more source

Angiotensin II Receptor Antagonist in Pregnancy [PDF]

Journal of Perinatology, 2003
openaire   +2 more sources

Angiotensin-converting enzyme inhibitors but not angiotensin II AT 1 receptor antagonists affect erythropoiesis in patients with anemia of end-stage renal disease [PDF]

, 1999
Lang, Susanne M., Schiffl, Helmut
core   +1 more source

Cost‐utility analysis of add‐on Qili Qiangxin capsules in chronic heart failure with reduced ejection fraction in China

ESC Heart Failure, EarlyView.
Abstract Aims The study aimed to analyse the cost‐utility of Chinese patent medicine Qili Qiangxin (QLQX) capsules in heart failure with a reduced ejection fraction from the healthcare payer's perspective. Methods and results From the perspective of the healthcare payer, a Markov model was established to estimate the cost‐utility of adding QLQX ...
Lu Wang, Yinglin Wang, Quan Zhao
wiley   +1 more source

Home-Based Care Management for Patients Post-Heart Failure Index Hospitalization: A Comprehensive Review. [PDF]

Cureus
Kerkar P, Harikrishnan S, Sawhney JS, Kapoor A, Gharat C.   +4 more
europepmc   +1 more source

Renal Protective Effects of Blocking the Intrarenal Renin-Angiotensin System: Angiotensin II Type I Receptor Antagonist Compared with Angiotensin-Converting Enzyme Inhibitor.

, 2000
Anyu Zhou, Ling Yu, Jingzi Li, Junfeng Zhang, Haiyan Wang   +4 more
openalex   +2 more sources

Early diuretic response and outcome prediction in ambulatory worsening heart failure: Natriuresis versus diuresis

ESC Heart Failure, EarlyView.
Abstract Aims Early diuresis and natriuresis are commonly used to assess the efficacy of decongestive therapy following an acute heart failure episode. There is limited knowledge regarding which parameter better predicts adverse clinical outcomes, especially in the outpatient setting.
M. Cobo Marcos, R. de la Espriella, I. Zegri‐Reiriz, P. Llacer, J. Rubio Gracia, J. Comín‐Colet, J. L. Morales‐Rull, P. Diez‐Villanueva, J. de Juan Bagudá, S. Jiménez‐Marrero, C. Ortiz Cortés, M. A. Restrepo‐Córdoba, J. M. García‐Pinilla, E. Barrios, S. del Prado Díaz, J. Núñez   +15 more
wiley   +1 more source

The role of endothelin receptor antagonists in kidney disease. [PDF]

Ren Fail
Ma X, Liang Y, Chen W, Zheng L, Lin H, Zhou T.   +5 more
europepmc   +1 more source

Effect of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Type 1 Receptor Antagonist on Metabolism and Contraction in Ischemia-Reperfused Rabbit Heart

, 2000
Hitoshi Kawabata, Teruhiko Ryomoto, Kinji Ishikawa   +2 more
openalex   +2 more sources